Intestinal trefoil factor (TFF 3) and pS2 (TFF 1), but not spasmolytic polypeptide (TFF 2) mRNAs are co-expressed in normal, hyperplastic, and neoplastic human breast epithelium
- 1 September 1997
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 183 (1) , 30-38
- https://doi.org/10.1002/(sici)1096-9896(199709)183:1<30::aid-path1085>3.0.co;2-k
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Gastric Mucosa Abnormalities and Tumorigenesis in Mice Lacking the pS2 Trefoil ProteinScience, 1996
- A second trefoil protein, ITF/hP1.B, is transcribed in human breast cancerBreast Cancer Research and Treatment, 1996
- Characterization of the Genomic Structure and the Promoter Region of the Human Intestinal Trefoil FactorBiochemical and Biophysical Research Communications, 1995
- Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomachThe Journal of Pathology, 1995
- Characterisation of the single copy trefoil peptides intestinal trefoil factor and pS2 and their ability to form covalent dimersFEBS Letters, 1995
- Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migrationGastroenterology, 1995
- Trefoil peptides promote epithelial migration through a transforming growth factor beta-independent pathway.Journal of Clinical Investigation, 1994
- Trefoil Peptides: A New Family of Gastrointestinal MoleculesDigestion, 1994
- The gene encoding the human spasmolytic protein (SML1hSP) is in 21q 22.3, physically linked to the homologous breast cancer marker gene BCEIpS2Genomics, 1992
- Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissuesThe Journal of Pathology, 1990